CytomX Therapeutics uses proprietary approaches for the development of new peptide-based therapeutics, diagnostics and reagents. We are working alone and with partners to discover peptides for incorporation in a variety of modular, site-directed molecules.
______________________________
As of February 1, 2008 the bioseparation technology of CytomX, LLC has become Cynvenio Biosystems.
You can find it here:
www.cynvenio.com
